Lin Health to Collaborate with Mayo Clinic to Expand Access to Evidence-Based, Tech-Enabled Chronic Pain Care
Lin Health, a digital platform helping people reclaim their lives from chronic pain, is collaborating with Mayo Clinic to ...
MIRA says Ketamir-2 outperforms FDA-approved neuropathic pain treatments
MIRA Pharmaceuticals (MIRA) announced that its novel oral ketamine analog, Ketamir-2, has shown greater pain relief compared to FDA-approved ...
Antidepressant recall: FDA upgrades medication risk class to 2nd highest level in recall update
The U.S. Food and Drug Administration is urging patients not to stop taking their prescribed medication if it falls under the ...
Black patients more likely to receive 'opioids only' pain relief after surgery
After Black patients undergo a surgery, they are much more likely than their White peers to receive only an opioid for ...
Studies of migraine’s many triggers offer paths to new therapies
AMY 1 receptors are found at key sites for migraine pain, such as the trigeminal nerves. In a small study, Russo and Hay ...
Black patients less likely to receive multimodal pain management options after surgery, research reveals
While recovering from major surgery, Black patients may be less likely to receive certain multimodal analgesia options and ...
Nationwide Antidepressant Recall Update As FDA Sets Risk Class
On October 11, the recall was classified as a class II recall by the FDA—a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health ...
MIRA Pharmaceuticals Announces Ketamir-2 Outperforms Current FDA-Approved Neuropathic Pain Treatments, Gabapentin and Pregabalin, in Preclinical Study
MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA), a leading pre-clinical-stage pharmaceutical development company, is excited to announce that its novel oral ketamine analog, Ketamir-2, has shown greater pain ...
healthday1d
Doctors More Likely to Order 'Opioids Only' for Black Patients After Surgery
After Black patients undergo a surgery, they are much more likely than their white peers to receive only an opioid for ...
FierceBiotech1d
Vertex posts full pain data ahead of FDA ruling, unpacking combo results, Vicodin miss and stellar safety
The FDA is set to rule on whether to approve suzetrigine by Jan. 30. Leerink analysts said they think the FDA could reach a ...
Journal.ie on MSN2d
Patients 'don't see an end' to their pain as they battle with waiting lists for management clinics
Use precise geolocation data. Actively scan device characteristics for identification. Store and/or access information on a ...
People of State Pension age with chronic pain could be due up to £108 each week
Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...